Every year, the Pharmacovigilance team of the Veterinary Sciences Department of the HPRA publishes an Annual Pharmacovigilance Report. Each annual report includes a summary and breakdown of all the adverse reactions/events notified to the HPRA as occurring in Ireland during that year. This includes reports of both serious and non-serious reactions/events in animals and humans, lack of expected efficacy (where the product has not worked as intended), maximum residue limit violations in food-producing species, adverse events on the environment or a combination of these report types.
The HPRA monitors the types of products involved, the nature of the reactions and the type of reporter in each case to gain a better understanding of the general awareness around safety monitoring of veterinary medicines amongst vets, vet nurses and animal owners.
The submission of reports of suspected adverse reactions/events is very important for all involved with the administration and use of veterinary medicines and enables the HPRA to closely monitor the safety profile of veterinary medicines in Ireland.
The annual pharmacovigilance reports provide a summary and analysis of the findings for that year and provides a summary of important safety-related topics that arose during the year.
In turn, these reports allow us to reflect and highlight areas where raised awareness, or additional information and/or guidance may be needed surrounding adverse reaction/event reporting and the safe use of veterinary medicines in general.
Each annual report listed by year, is available to read below.
Annual pharmacovigilance report 2021
Annual pharmacovigilance report 2020
Annual pharmacovigilance report 2019
Annual pharmacovigilance report 2017 - 2018
Annual pharmacovigilance report 2015 - 2016
Annual pharmacovigilance report 2014